Synthesis and biological evaluation of guanidino analogues of roscovitine
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F13%3A33147876" target="_blank" >RIV/61989592:15310/13:33147876 - isvavai.cz</a>
Alternative codes found
RIV/61389030:_____/13:00396979 RIV/61388963:_____/13:00396979 RIV/61989592:15110/13:33147876
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S0223523413000494" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0223523413000494</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejmech.2013.01.021" target="_blank" >10.1016/j.ejmech.2013.01.021</a>
Alternative languages
Result language
angličtina
Original language name
Synthesis and biological evaluation of guanidino analogues of roscovitine
Original language description
A series of 2,9-substituted 6-guanidinopurines, structurally related to the cyclin-dependent kinase (CDK) inhibitors olomoucine and roscovitine, has been synthesized and characterized. A new copper-catalyzed method for the synthesis of 2-substituted 6-guanidino-9-isopropylpurines under mild reaction conditions has been developed. All prepared compounds were screened for their CDK1 and CDK2 inhibitory activities, cytotoxicity and antiproliferative effects in the breast cancer-derived cell line MCF7. Themost active derivative 16g possessed an identical side chain in the C2 position to roscovitine; this compound displayed approximately five fold higher inhibitory activity towards CDK2/cyclin E and more than ten fold increase in cytotoxicity in MCF7 cells. Interestingly and in contrast to previously described findings, (S)-6-guanidinopurine derivatives were generally more active than their (R)-counterparts. Kinase selectivity profiling of (R)- and (S)-enantiomers 16e and 16g, respectively
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
ED - Physiology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Journal of Medicinal Chemistry
ISSN
0223-5234
e-ISSN
—
Volume of the periodical
62
Issue of the periodical within the volume
APR
Country of publishing house
FR - FRANCE
Number of pages
10
Pages from-to
443-452
UT code for WoS article
000318577500046
EID of the result in the Scopus database
—